8019-5053 Screening compound: N-(2-{[3-(3,4-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]formamido}ethyl)-3-methoxybenzamide

8019-5053 Screening compound: N-(2-{[3-(3,4-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]formamido}ethyl)-3-methoxybenzamide
8019-5053 Screening compound: N-(2-{[3-(3,4-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]formamido}ethyl)-3-methoxybenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 8019-5053
N-(2-{[3-(3,4-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]formamido}ethyl)-3-methoxybenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

8019-5053

Molecular Formula

C21H22N4O6 (C21 H22 N4 O6)

Compound Name

N-(2-{[3-(3,4-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]formamido}ethyl)-3-methoxybenzamide

IUPAC name

N-(2-{[3-(34-dimethoxyphenyl)-124-oxadiazol-5-yl]formamido}ethyl)-3-methoxybenzamide

SMILES

COc1cccc(C(NCCNC(c2nc(-c(cc3)cc(OC)c3OC)no2)=O)=O)c1

InChI

InChI=1S/C21H22N4O6/c1-28-15-6-4-5-14(11-15)19(26)22-9-10-23-20(27)21-24-18(25-31-21)13-7-8-16(29-2)17(12-13)30-3/h4-8,11-12H,9-10H2,1-3H3,(H,22,26)(H,23,27)

InChI Key

NWVYWFDKLRECOE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD08094024

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

426.43

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

1.839

Distribution Coefficient, logD

1.839

Water Solubility, LogSw

-2.24

Polar Surface Area

103.502

Acid Dissociation Constant (pKa)

13.81

Base Dissociation Constant (pKb)

-2.24

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

23.80

8019-5053 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Others
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with 8019-5053 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 8019-5053?
Check Price and Availability of 8019-5053, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 8019-5053 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 8019-5053
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 8019-5053
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 8019-5053 available by request